Buscar
01/12/2022
Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners
Chazan, G, Jupp, J, Bauters, T, Duncan, N, Weddle, KJ, Nomura, H, O'Connor, S, Chan, A, Alkhudair, N, Alsamrani, M, Buie, LW, Chambers, P, Chieh, TW, DeRemer, DL, Duvivier, F, Katabalo, D, McFarlane, T, Mckavanagh, D, Mensah, K, Martinez, EM, Rowan, G, Sae-teaw, M, Tadesse, TA, Weru, I, Alexander, M. Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2022; 28(8)DOI:10.1177/10781552211048892. PMID:34693814. IF:1.300(Q4/10D).
01/09/2022
Validation protocol of the LESS-CHRON deprescription tool in multimorbidity patients. LESS-CHRON-VALIDATION Project
Rodriguez-de Francisco, L, Rodriguez-Perez, A, Mejias-Trueba, M, Beobide-Telleria, I, Juanes-Borrego, AM, Saavedra-Quiros, V, Carrion-Madronal, IM. Validation protocol of the LESS-CHRON deprescription tool in multimorbidity patients. LESS-CHRON-VALIDATION Project. Farmacia Hospitalaria. 2022; 46(5)DOI:10.7399/fh.13268. PMID:36183233. IF:(Q/D).
01/09/2022
PAUSATE Study: Prevalence and appropriateness of the use of antimicrobials in Spanish hospitals
Gutierrez-Urbon, JM, Arenere-Mendoza, M, Fernandez-de-Gamarra-Martinez, E, Fernandez-Polo, A, Gonzalez-Suarez, S, Nicolas-Pico, J, Rodriguez-Mateos, ME, Sanchez-Yanez, E. PAUSATE Study: Prevalence and appropriateness of the use of antimicrobials in Spanish hospitals. Farmacia Hospitalaria. 2022; 46(5)DOI:10.7399/fh.13152. PMID:36183227. IF:(Q/D).
01/09/2022
Drug-drug interactions in an intensive care unit and comparison of updates in two databases
Riera, P, Sole, N, Suarez, JC, Lopez, PA, Fonts, N, Rodriguez-Farre, N, de Gamarra-Martinez, EF, Moran, I. Drug-drug interactions in an intensive care unit and comparison of updates in two databases. Farmacia Hospitalaria. 2022; 46(5)DOI:10.7399/fh.13180. PMID:36183229. IF:(Q/D).
01/08/2022
Chronic hypogammaglobulinemia after allogeneic stem cell transplantation and their treatment with subcutanaeos inmunoglobulin in pediatric patients
Serra Font S., López-Granados L., Sisinni L., Serna Berna J.V., Martínez Martínez L., Fernández de Gamarra-Martínez E., de la Calle Martín O., Badell Serra I.. Chronic hypogammaglobulinemia after allogeneic stem cell transplantation and their treatment with subcutanaeos inmunoglobulin in pediatric patients. ANALES DE PEDIATRIA. 2022; 97(2)DOI:10.1016/j.anpedi.2021.08.011. PMID:35869014. IF:2.100(Q3/6D).
01/05/2022
Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain
Moreno-Martinez, E, de la Serna-Torroba, J, Escudero-Vilaplana, V, Hernandez-Rivas, JA, Sanchez-Cuervos, M, Sanchez-Hernandez, R. Cost-utility analysis of venetoclax in combination with obinutuzumab as first-line treatment of chronic lymphocytic leukaemia in Spain. Farmacia Hospitalaria. 2022; 46(3)DOI:10.7399/fh.11829. PMID:36183205. IF:(Q/D).